Loading company…
GLYPHIC BIOTECHNOLOGIES, INC.
PrivateWon 5 federal SBIR/STTR research awards from DOD and other federal agencies.
Department of DefenseDefense Health Agency
- SAM UEI
- F57WT7JZDH19
- Founded
- —Source: [GOV]
- Headquarters
- NEW YORK, New YorkSource: [GOV]
- Country
- United StatesSource: [GOV]
- Headcount
- 18Source: [GOV]
- Stage
Sign inTotal raised
UndisclosedSource: [GOV]Last valuation
Overview
GLYPHIC BIOTECHNOLOGIES, INC. has been awarded 5 US Small Business Innovation Research (SBIR/STTR) contracts totalling $1,817,792 between 2022 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in NEW YORK, New York.
Funding rounds
6 rounds6 rounds · latest STTR Phase I award (DOD), Apr 2024
Sign in to see 6 rounds.
Sign inInvestors
6 on fileSign in to see 6 investors.
Sign inPeople
LeadershipAcquisitions
GLYPHIC BIOTECHNOLOGIES, INC. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for GLYPHIC BIOTECHNOLOGIES, INC..
Add diversity data